Aristotle University Of Thessaloniki (AUTH)
H διαγνωστική ακρίβεια της υπερηχογραφικής ελαστογραφίας πίεσης στην κυτταρολογική διάγνωση κακοήθειας σε όζους του θυρεοειδή αδένα
Abstract
dc:descriptionElastography is an important non-invasive ultrasonographic imaging modality that assesses tissue stiffness, thereby contributing to the diagnosis of suspicious thyroid nodules. Two main types are currently used: strain elastography (SE), which is based on manual compression with the ultrasound probe and provides qualitative color-coded stiffness maps, and shear wave elastography (SWE), which measures the propagation velocity of shear waves and additionally provides quantitative elasticity values of the examined tissues. SWE demonstrates superior reproducibility and objectivity, whereas SE remains particularly useful in very stiff lesions, in which SWE may show reduced diagnostic accuracy. The two techniques are considered complementary and, in selected cases, are used in combination with conventional ultrasonography to optimize diagnostic performance. In thyroid nodules, vascularity assessment using color Doppler imaging may provide predictive information regarding nodule characteristics; however, its reliability remains limited due to dependence on both the ultrasound equipment and the operator, and therefore it has not been incorporated into thyroid nodule risk stratification systems. The present study was designed as a diagnostic accuracy cohort study and aimed to evaluate the combined use of strain elastography and the American College of Radiology Risk Stratification System (ACR TI-RADS; American College of Radiology Thyroid Imaging Reporting and Data System) for the diagnosis of thyroid nodule malignancy, with the goal of reducing unnecessary fine-needle aspiration biopsies (FNABs). The primary objective was to determine elastographic cut-off values capable of improving the sensitivity and specificity of ACR TI-RADS in predicting malignancy and to investigate the potential additive diagnostic value of elastography in more accurate malignancy detection. Secondary objectives included the evaluation of factors potentially influencing elastography results, such as age, sex, the presence of Hashimoto’s thyroiditis and hypothyroidism, as well as the method used for calculating relative nodule stiffness (comparison with thyroid parenchyma versus the adjacent sternocleidomastoid muscle). The study further aimed to develop non-invasive diagnostic approaches that could improve diagnostic accuracy while reducing healthcare costs and the need for surgical intervention. The study included patients with nodular thyroid disease who underwent routine evaluation and fulfilled the inclusion criteria, whereas individuals with a history of radioactive iodine treatment, pregnancy, or other conditions affecting thyroid tissue stiffness were excluded. A total of 3,150 patients were evaluated between April 2023 and May 2025. Data were recorded in accordance with personal data protection regulations and included demographic characteristics, thyroid function parameters, conventional two-dimensional ultrasonography (B-mode imaging), and nodule classification according to both the ACR TI-RADS and the European classification system (EU-TIRADS). In patients for whom FNAB was recommended according to ACR TI-RADS criteria, cytological findings were documented, while histopathological diagnoses were recorded for patients who subsequently underwent thyroidectomy. In addition, the stiffness ratio (E2/E1) was calculated using strain elastography, and nodule vascularization patterns were assessed using color Doppler imaging. Evaluated vascularization parameters included peripheral, central, mixed, or absent vascularity. Among the 574 patients who fulfilled the criteria for FNAB, the EU-TIRADS system recommended biopsy in a greater number of patients (n = 747) compared with ACR TI-RADS (n = 574), although the difference was not statistically significant (P = 0.939). In the TR3 category, the difference was more pronounced, with 169 patients requiring FNAB according to ACR TI-RADS versus 305 according to EU-TIRADS (P < 0.001). Of the 556 patients who ultimately underwent biopsy, 56 demonstrated cytological findings suspicious for malignancy (Bethesda categories IV, V, and VI), while 22 had indeterminate cytology (Bethesda category III); these patients underwent surgical treatment. Histopathological examination confirmed papillary thyroid carcinoma in 55 patients. Further statistical analysis demonstrated that the elastographic ratio ER = E2/E1 (defined as the stiffness ratio between the thyroid nodule and the adjacent sternocleidomastoid muscle) was significantly associated with an increased likelihood of malignancy (OR = 5.6, P < 0.001). Multivariate analysis including variables such as sex, age, body mass index (BMI), thyroiditis, hypothyroidism, nodule size, vascularity, and elastographic ratio demonstrated that only autoimmune thyroiditis, absence of vascularity, and the elastographic ratio significantly influenced the probability of malignancy. Elastography using an ER threshold >1.1315 yielded a sensitivity of 76.36% and a specificity of 87.23% for malignancy detection.Using an ER threshold >1.937 in the subgroup of nodules with a diameter ≥25 mm, 240 biopsies of ultimately benign nodules could potentially have been avoided. When patients were stratified according to ACR TI-RADS category (TR3, TR4, and TR5), elastography demonstrated significant additive diagnostic value for malignancy detection, reducing the total number of biopsies across all subcategories. In the TR3 category, application of the elastographic criterion ER >1.6 avoided 159 biopsies (96.9% of biopsies recommended according to ACR TI-RADS criteria for ultimately benign nodules). In the TR4 category, application of the ER >1.37 criterion avoided 276 biopsies (88.5%). Finally, in the TR5 category, recommending FNAB only for nodules with ER >0.953 avoided 23 biopsies (79.3%). However, based on the aforementioned elastographic thresholds, the number of malignant nodules that would not have been diagnosed according to each TI-RADS category was as follows: TR3, 0/4; TR4, 6/31; and TR5, 6/20, corresponding overall to 12 of 55 patients with confirmed malignancy. To improve the sensitivity of the method, elastographic thresholds were recalculated separately for each category in order to avoid missing any confirmed malignant cases. The results demonstrated that, in the TR4 category, an elastographic threshold <0.44 reduced unnecessary biopsies by 71 out of 312 cases (22.8%), whereas in the TR5 category, a threshold <0.54 reduced unnecessary FNABs by 11 out of 29 cases (38%). Therefore, the application of these revised thresholds as additional criteria for avoiding biopsy—according to the TI-RADS category assigned to each nodule—could substantially reduce the total number of biopsies performed on benign nodules, almost by half (from 501 biopsies based solely on ACR TI-RADS recommendations to 260 when elastographic criteria were additionally applied).Furthermore, the study evaluated the diagnostic value of nodule vascularity, focusing specifically on nodules already fulfilling FNAB criteria. Vascularity analysis was performed separately for each ACR TI-RADS category. Although this approach reduced the number of evaluated nodules and potentially limited statistical power, the findings demonstrated that the presence of internal vascularity constituted a clear risk factor for malignancy. Specifically, central vascularity increased the likelihood of malignancy by 1.5-fold in the TR5 category and by 1.3-fold in the TR3 and TR4 categories. In particular, within the TR3 category, which encompasses the majority of thyroid nodules encountered in routine clinical practice, the presence of mixed vascularity increased the indication for FNAB by 1.7-fold (69.4%) compared with other vascularity patterns, indicating that nodules considered more suspicious according to TI-RADS criteria frequently demonstrate central vascularity (either exclusively central or mixed vascularity).Regarding demographic characteristics, age stratification of the study population demonstrated a progressive reduction in the prevalence of malignant cytology with increasing age across the 18–39, 40–59, and ≥60 year age groups: 22.7%, 8.9%, and 7.5%, respectively. Age ≤52 years increased the risk of malignancy by 2.3-fold compared with patients aged >52 years (OR 2.26; 95% CI: 1.3–4.4; P = 0.008). Univariate analysis identified age, sex, and nodule size as significant risk factors for malignant cytology. Specifically, each additional year of age was associated with a 2.8% reduction in the odds ratio (OR) for malignant cytology (95% CI: 1.1%–3.1%; P < 0.001). Male sex and nodule size were associated with an increased risk of malignancy, with ORs of 2.099 (95% CI: 1.133–3.889; P = 0.018) and 0.892 (95% CI: 0.848–0.939; P < 0.001), respectively. In contrast, BMI, autoimmune thyroiditis, and levothyroxine treatment were not significantly associated with malignancy. In multivariate logistic regression analysis, each one-year increase in age was associated with a 2.7% reduction in the relative probability of malignancy. In conclusion, with regard to routine clinical practice, the implementation of elastographic thresholds below which thyroid nodule biopsy may be safely avoided—even when FNAB is recommended according to the corresponding ACR TI-RADS category—may substantially reduce the number of unnecessary biopsies without significantly increasing the risk of missing malignant cases.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angelopoulos, Nikolaos
- Αγγελόπουλος, Νικόλαος
Subjects
dc:subject × 16- Θυρεοειδής αδένας
- Θυρεοειδικός καρκίνος
- Ελαστογραφία
- Έγχρωμη υπερηχογραφία
- Thyroid
- Thyroid cancer
- Elastography
- Color doppler
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Ραδιολογία, Πυρηνική ιατρική και Απεικονιστική
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
- Radiology, Nuclear Medicine and Imaging
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62316